Lithium Controlled-Release and Extended-Release Tablets and Von willebrand factor recombinant Intravenous
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Von willebrand factor recombinant Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: von willebrand factor
Brand name: Vonvendi, Wilfactin
Synonyms: Von Willebrand factor (recombinant), von Willebrand Factor (Recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Vonvendi
- Lithium Controlled-Release and Extended-Release Tablets-Vopac
- Lithium Controlled-Release and Extended-Release Tablets-Vopac MDS
- Lithium Controlled-Release and Extended-Release Tablets-Vorapaxar
- Lithium Controlled-Release and Extended-Release Tablets-Vorapaxar Sulfate
- Lithium Controlled-Release and Extended-Release Tablets-Voraxaze
- Von willebrand factor recombinant Intravenous-Lithium ER
- Von willebrand factor recombinant Intravenous-Lithium Oral Solution
- Von willebrand factor recombinant Intravenous-Lithium Salts
- Von willebrand factor recombinant Intravenous-Lithium Syrup and Oral Solution
- Von willebrand factor recombinant Intravenous-Lithobid
- Von willebrand factor recombinant Intravenous-Lithostat